← FDA Drug Approvals (Drugs@FDA)

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-03-30

Drug application

FDA Application #

ANDA208449

Application type

Abbreviated New Drug Application (Generic)

Brand name

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Generic name

Linagliptin

Active ingredients

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

First approval

2023-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown